Diagnosis of all of the PTC patients [including lymph node metastasis (LNM), HT, and BRAF V600E mutation] was histologically confirmed by two independent pathologists. The gene discussed is BRAF; the disease is metastatic malignant neoplasm in the lymph nodes.